Mercedes Is Teasing a New V-12-Run Maybach S-Class

Freda Walters

This yr marks Maybach’s 100th anniversary, and to rejoice the occasion, the extremely-high-class Mercedes-Benz sub-manufacturer will seemingly drop a new design. Judging by the one impression introduced higher than, it appears like we’ll be seeing a new V-12-run S-Class in the close to long run.

In an announcement Thursday, Mercedes highlighted Maybach’s illustrious background as a standalone manufacturer and afterwards as a sub-division, immediately after legal rights to the organization were purchased in 1961. Accompanying the press launch is a solitary profile impression of a Maybach-badged S-Course with a reflection of a 22/70 HP W 3—Maybach’s to start with collection manufacturing model. The most telling piece of facts in the image? A “V12” badged caught to the front fender of the new motor vehicle.

Right now, the only Maybach-branded autos you can obtain are the Mercedes-Maybach S 580 and the Mercedes-Maybach GLS 600—neither of which are V-12-driven. Curiously, Mercedes does not point out the pictured vehicle in the release, only that it really is making ready “various initiatives that celebrate [Maybach’s] spirit come to life” in 2021.

This articles is imported from YouTube. You could be capable to come across the identical material in a further format, or you may well be in a position to find far more info, at their world wide web web-site.

We’ve recognised since 2018 that Mercedes would get started to action away from V-12 ability in its AMG products, but would proceed to use the motor in its deluxe Maybach offerings. If we experienced to guess, the car shown here is most likely a new S 650.

This content is made and managed by a 3rd social gathering, and imported on to this website page to help users supply their email addresses. You may be able to uncover much more data about this and comparable information at

Next Post

Anixa Biosciences and Moffitt Cancer Heart Report US Food and drug administration Ask for of Added Info for Car-T Therapy

SAN JOSE, Calif., April 19, 2021 /PRNewswire/ — Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology business focused on the treatment method and avoidance of most cancers and infectious disorders, announced these days that the U.S. Food items and Drug Administration (US Food and drug administration) has requested extra details about its […]

Subscribe US Now